FOLFOX-HAIC as Conversion Treatment for Initially Unresectable Colorectal Liver Metastasis

NCT06988852 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Liver Metastasis (CRLM)

Interventions

COMBINATION_PRODUCT: FOLFOX (oxaliplatin, leucovorin, 5-fluorouracil [5FU])
PROCEDURE: hepatic arterial infusion chemotherapy (HAIC)
DRUG: Bevacizumab
DRUG: Cetuximab (Erbitux)
PROCEDURE: liver resection

Sponsor

Tongji Hospital